Related Experiment Video
Updated: Aug 8, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Percutaneous double balloon valvotomy for severe rheumatic mitral stenosis
1Department of Interventional Cardiology, Hospital of the Good Samaritan, Los Angeles, California 90017.
The American Journal of Cardiology
|February 15, 1990
Summary
Percutaneous double balloon mitral valvotomy is a safe and effective treatment for severe rheumatic mitral stenosis. This minimally invasive procedure significantly improves cardiac function and patient symptoms with a low risk of complications.
Area of Science:
- Cardiology
- Interventional Cardiology
- Valvular Heart Disease
Background:
- Rheumatic mitral stenosis is a significant cause of morbidity and mortality.
- Severe mitral stenosis impairs cardiac function and quality of life.
- Percutaneous mitral balloon valvotomy offers a less invasive treatment option.
Purpose of the Study:
- To evaluate the efficacy and safety of percutaneous double balloon mitral valvotomy.
- To assess the hemodynamic and clinical outcomes of the procedure.
- To determine the feasibility of this intervention in a large patient cohort.
Main Methods:
- A consecutive series of 285 patients with severe rheumatic mitral stenosis underwent percutaneous double balloon valvotomy.
- Hemodynamic parameters including transvalvular gradient, cardiac output, and pulmonary pressures were measured.
- Mitral valve area and procedural success rates were assessed.
- Clinical outcomes and complications were meticulously recorded.
Main Results:
- Successful valvotomy was achieved in 281 of 285 patients (98.6%).
- Significant improvements were observed in mitral valve area (0.86 to 2.41 cm2), cardiac output (3.8 to 5.4 L/min), and reductions in transvalvular gradient and pulmonary pressures.
- 95% of patients reported symptomatic improvement.
- A low procedure-related mortality rate of 1% was noted, with no significant post-procedural mitral regurgitation.
Conclusions:
- Percutaneous double balloon mitral valvotomy is a low-risk, highly effective treatment for severe rheumatic mitral stenosis.
- The procedure leads to substantial hemodynamic improvements and significant symptomatic relief.
- Rapid recovery and favorable long-term outcomes can be expected.
Related Concept Videos
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...